can you lie about your weight to get semaglutide Semaglutide: Transform Health & Loss Semaglutide Must Be Taken for

The most commonly reported adverse effects are gastrointestinal in nature , affecting a significant proportion of patients, particularly during the initial weeks of treatment or following dose escalation

Manufacturers have ramped up production to avoid the shortages previously seen with injectable GLP-1s, aiming for a consistent supply chain for this new oral option

The SELECT trial further showed that once-weekly semaglutide reduced first-event MACE by 20% in adults with obesity and prior cerebrovascular disease, extending cardiovascular protection beyond diabetes [319, 320]

The trade-off is that daily injections require more discipline and create more opportunities to miss doses, which can reduce effectiveness